RPG Life Sciences Ltd.
BSE: 532983 | Sector: Health care |
NSE: RPGLIFE | ISIN Code: INE105J01010 |
BSE 00:00 | 24 May | 494.60 |
-3.75 (-0.75%) |
OPEN
498.00 |
HIGH
504.95 |
LOW
491.90 |
NSE 00:00 | 24 May | 497.00 |
-0.80 (-0.16%) |
OPEN
493.15 |
HIGH
507.65 |
LOW
490.45 |
OPEN | 498.00 |
PREVIOUS CLOSE | 498.35 |
VOLUME | 554 |
52-Week high | 751.80 |
52-Week low | 425.00 |
P/E | 15.89 |
Mkt Cap.(Rs cr) | 818 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
RPG Life Sciences Ltd. (RPGLIFE) - Net Sales
Market Cap
COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
Aurobindo Pharma | 538.60 | -20.25 | -3.62 | 15823.68 |
Cipla | 970.50 | -0.05 | -0.01 | 13900.58 |
Dr Reddy's Labs | 4351.10 | 76.85 | 1.80 | 13349.10 |
Sun Pharma.Inds. | 910.20 | -11.25 | -1.22 | 12803.21 |
Lupin | 601.15 | -17.25 | -2.79 | 11055.93 |
Apollo Hospitals | 3632.40 | -89.15 | -2.40 | 9153.00 |
Zydus Lifesci. | 368.15 | 5.75 | 1.59 | 7790.40 |
Glenmark Pharma. | 394.55 | -8.85 | -2.19 | 7567.93 |
Alkem Lab | 2932.40 | -52.65 | -1.76 | 7219.68 |
Divi's Lab. | 3662.05 | -235.50 | -6.04 | 6798.61 |
Torrent Pharma. | 2592.50 | -23.60 | -0.90 | 6450.83 |
Ipca Labs. | 955.60 | -21.45 | -2.20 | 5114.11 |
Alembic Pharma | 756.35 | -4.05 | -0.53 | 5051.44 |
Laurus Labs | 567.15 | -5.40 | -0.94 | 4768.72 |
Abbott India | 18191.80 | 439.30 | 2.47 | 4310.02 |
Gland Pharma | 2871.65 | -109.30 | -3.67 | 3462.88 |
Glaxosmi. Pharma | 1553.75 | -1.30 | -0.08 | 3193.74 |
Granules India | 280.75 | 0.60 | 0.21 | 3134.98 |
Sanofi India | 6587.80 | -48.65 | -0.73 | 2956.60 |
Ajanta Pharma | 1699.30 | -26.80 | -1.55 | 2718.59 |
Quick Links for RPG Life Sciences:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices